(Q55545970)

English

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease.

scientific article published on 19 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease. (English)

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Johannes Kornhuber

6

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Hans-Jürgen Möller

11

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

15 July 2018

15

object named as

Birgitt Wiese

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

4

object named as

Frank Jessen

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

author name string

Oliver Peters

1

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Manuel Fuentes

2

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Lisa Katharina Joachim

3

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Christian Luckhaus

5

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Johannes Pantel

7

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Michael Hüll

8

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Klaus Schmidtke

9

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Eckart Rüther

10

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Alexander Kurz

12

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Jens Wiltfang

13

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Wolfgang Maier

14

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Lutz Frölich

16

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Isabella Heuser

17

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

publication date

19 October 2015

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Alzheimer's & dementia (New York, N. Y.)

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

1

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

3

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

198-204

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

27 July 2018

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

27 July 2018

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

27 July 2018

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

27 July 2018

Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

27 July 2018

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Combination therapy for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Commentary on "Meta-analysis of six-month memantine trials in Alzheimer's disease." Memantine has negligible benefits in mild to moderate Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5975055

12 August 2018

Identifiers

10.1016/J.TRCI.2015.10.001

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/5975055

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55545970&oldid=1784740407"